Director Amit Agarwal sold 20,000 shares at blended avg $220.92 on 2026-06-18 under 10b5-1 plan
Amit Agarwal executed 9 separate sales totaling 20,000 shares for $4,418,365.06 on 2026-06-18, reducing his non-derivative holdings from 21,640 to 1,640 shares, though he retains 350,059 derivative shares through a trust vehicle. This sale was executed under a pre-arranged 10b5-1 trading plan, making it a scheduled transaction rather than a discretionary decision. The stock price has declined 20.9% from its 52-week high of $278.70 to the current $220.57, yet has gained 78.9% over the past 90 days. The company reported strong fundamentals with revenue of $1,006,426,000 and annual revenue growth of 27.7%, though the elevated P/E of 711.52 warrants attention. While Agarwal's cross-ticker track record shows an average 30-day return of +30.6% after prior sells, the current filing is mechanically scheduled under the 10b5-1 plan rather than discretionary, so prior timing outcomes do not characterize this particular execution.